Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/30/2007
 
First Published:
6/23/2004
1.
Phase II Study of Intratumoral Fowlpox-TRICOM in Patients With Metastatic Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
UCCRC-12759A
NCI-6038, 6038, NCT00087373
Last Modified:
1/31/2003
 
First Published:
7/1/2001
2.
Phase I Pilot Study of Recombinant Fowlpox-TRICOM Vaccine in Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx or Nodal or Dermal Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
Other
NCI-01-DC-0006
NCI-3210, NCT00021424
Last Modified:
10/31/2006
 
First Published:
2/1/2002
3.
Phase I Randomized Study of Intratumoral rF-B7.1 Vaccine Versus Recombinant Fowlpox-TRICOM Vaccine in Patients With Metastatic Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
CPMC-IRB-14535
AECM-01-122, NCI-3351, CPMC-IRB-01-122, NCT00030693, 3351
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute